StonvexLoading…
StonvexStonvexStonvexCore line items from BLZE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $38.67M | $145.84M | $108.07M | $70.91M |
Operating Income | $-5.35M | $-23.62M | $-18.96M | $-15.64M |
Net Income | $-6.15M | $-25.61M | $-20.20M | $-16.42M |
EPS (Diluted) | $-0.10 | $-0.46 | $-0.36 | $-0.30 |
Total Assets | $192.67M | $191.83M | $191.53M | $186.04M |
Total Liabilities | $108.02M | $108.61M | $108.70M | $106.40M |
Cash & Equivalents | $26.28M | $29.18M | $29.08M | $32.19M |
Free Cash Flow OCF − CapEx | $2.71M | $18.85M | $9.80M | $7.20M |
Shares Outstanding | 59.29M | 56.21M | 55.56M | 54.84M |